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A construct consisting of residues 10–310 of BipD, a component of the
Burkholderia pseudomallei type III secretion system (T3SS), has been
overexpressed as a GST fusion, cleaved from the GST tag and puriﬁed.
Crystals were grown of native and selenomethionine-labelled BipD. The crystals
grow in two different polymorphs from the same condition. The ﬁrst polymorph
belongs to space group C222, with unit-cell parameters a = 103.98, b = 122.79,
c = 49.17 A ˚ , a calculated Matthews coefﬁcient of 2.4 A ˚ 3 Da
 1 (47% solvent
content) and one molecule per asymmetric unit. The second polymorph belongs
tospacegroupP21212,withunit-cellparametersa=136.47,b=89.84,c=50.15 A ˚ ,
and a calculated Matthews coefﬁcient of 2.3 A ˚ 3 Da
 1 (45% solvent content) for
two molecules per asymmetric unit (analysis of the self-rotation function
indicates the presence of a weak twofold non-crystallographic symmetry axis in
this P21212 form). The native crystals of both forms give diffraction data to 2.7 A ˚
resolution, while the SeMet-labelled P21212 crystals diffract to 3.3 A ˚ resolution.
AK 2PtCl4 derivative of the P21212 form was also obtained and data were
collected to 2.7 A ˚ with radiation of wavelength   = 0.933 A ˚ . The Pt-derivative
anomalous difference Patterson map revealed two self-peaks on the Harker
sections.
1. Introduction
Type III secretion systems (T3SSs) are essential virulence determi-
nants of many Gram-negative bacterial pathogens. The T3SS is
required to translocate virulence effectors into the host cell. The
T3SS consists of a ‘needle complex’ composed of an external hollow
needle held within a basal body that traverses both bacterial
membranes. Secretion is activated by contact of the tip of the needle
with host cells, resulting in the formation of a pore in the host-cell
membrane that is contiguous with the needle. Other effector proteins
are injected via this apparatus directly into the host-cell cytoplasm
(for a review, see Johnson et al., 2005).
Among Gram-negative bacteria that possess a T3SS, the
Burkholderia species are highly pathogenic to humans. They have
been listed as biological risk category B agents and as a consequence
of their infectivity by the respiratory route are considered potential
bioterror agents (Rotz et al., 2002). B. pseudomallei causes melioid-
osis in humans, a disease endemic in Southeast Asia and Northern
Australia. This disease presents in a variety of ways from subacute
and chronic suppurative infections to a rapidly fatal septicaemia
(White, 2003). B. mallei causes the zoonotic disease glanders, mainly
in horses. B. mallei can also infect humans, an infection that is almost
invariably fatal if untreated (Wilkinson, 1981).
The B. pseudomallei needle is composed of the  9 kDa protein
BsaL, the structure of which has been determined by NMR (Zhang et
al., 2006) and is homologous both in sequence and structure to the
Shigella ﬂexneri needle component MxiH. We have recently deter-
mined the crystal structure of MxiH and assembled a molecular
model of the T3SS needle, docking its crystal structure into a 16 A ˚
EM reconstruction of the S. ﬂexneri needle (Cordes et al., 2005;
Deane, Cordes et al., 2006; Deane, Roversi et al., 2006). As part of our
ongoing structural effort to further characterize the T3SS needle
# 2006 International Union of Crystallography
All rights reservedmachinery, we have now endeavoured to express, purify and crys-
tallize the B. pseudomallei BipD protein, a key component of the
translocation apparatus in this bacterium. BipD is required for full
virulence in murine models of melioidosis and mutation of the
B. pseudomallei bipD gene impairs invasion of epithelial cells in vitro
(Stevens & Galyov, 2004; Stevens et al., 2004).
There are no close BipD sequence homologues of known structure,
the closest (13% sequence identity) being LcrV (Derewenda et al.,
2004), a T3SS component of Yersinia pestis, which has been shown to
be located at the tip of the T3SS needle and is similarly needed for
cell invasion (Mota, 2006). The closest sequence homologues of BipD
are Shigella IpaD and Salmonella SipD (36% and 33% sequence
identity to BipD, respectively); together with some enteropathogenic
Escherichia coli and Chromobacterium violaceum proteins, they form
the T3SS protein family called ‘invasion plasmid antigen IpaD
proteins’ (Bateman et al., 2004). A three-dimensional structure of
Burkholderia BipD, together with the structure of Yersinia LcrV
(Derewenda et al., 2004), should increase our understanding of their
role in T3SS pathogenesis.
2. Experimental procedures
2.1. Protein expression and purification
The construction of the pGEXBipD plasmid used for expression of
the GST-BipD fusion protein has been described previously (Stevens
et al., 2002). The plasmid was transformed into E. coli BL21 strain.
The bacteria were grown in LB at 310 K overnight. 10 ml of the
overnight culture was inoculated into 400 ml fresh LB and grown for
2.5 h at 310 K with shaking, induced with 100 ml1 M IPTG and
incubated for a further 2.5 h. The bacteria were pelleted by centri-
fugation, resuspended in 20 ml TBS (10 mM Tris–HCl pH 8, 150 mM
NaCl) and sonicated using a Heat Systems Inc. sonicator Model
XL2020 (5   10 s sonication followed by 10 s pause) with a half-inch
disruptor horn at output setting 4. The debris was removed by
centrifugation. 800 ml of a 50% suspension of glutathione Sepharose
4B beads (Amersham) was added to the supernatant and incubated
for 30 min at room temperature. The beads were washed three times
with TBS. The pelleted beads were resuspended in 200 ml TBS
containing 10 units of thrombin (Sigma) and incubated on a rotating-
plate mixer for 14 h at room temperature. The supernatant containing
released BipD was collected.
The protein was further puriﬁed by gel ﬁltration, injecting about
3 ml at a concentration of 0.5 mg ml
 1 onto an S75 16/60 FPLC
column (Amersham) running at 1 ml min
 1 in 20 mM Tris–HCl pH
6.6 and 20 mM NaCl running buffer. Six 2 ml fractions containing the
protein were collected and concentrated by centrifugation in 10 kDa
molecular-weight cutoff Vivaspin centrifugal concentrators
(VivaScience, Sartorius Group) to a concentration of 10 mg ml
 1 at
277 K.
SeMet-labelled BipD was produced by expression in the E. coli
methionine-auxotrophic strain B834 (DE3). Cultures were grown in
LB media toan A600nm of0.2, pelleted (15 min, 4000g, 277 K), washed
in PBS three times and resuspended in 10 ml SeMet medium without
SeMet before being used to inoculate SelenoMet Medium Base
containing SelenoMet Nutrient Mix and SeMet stock solution (4 ml
per litre; Molecular Dimensions, UK). Cells were grown and induced
as described above. SeMet-labelled protein was puriﬁed as described
above. Full incorporation of selenomethionine was conﬁrmed by
mass spectrometry (data not shown).
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Table 1
BipD X-ray diffraction data-collection statistics.
Value in parentheses are for the highest resolution shells.
Native 1 Native 2 SeMet K2PtCl4 soak
X-ray source ESRF ID29 ESRF ID14-2 ESRF ID29 ESRF ID14-2
Detector ADSC scanner ADSC scanner ADSC scanner ADSC scanner
Space group C222 P21212 P21212 P21212
Z 8888
Unit-cell parameters
a (A ˚ ) 103.98 136.47 135.90 136.52
b (A ˚ ) 122.79 89.84 89.50 89.55
c (A ˚ ) 49.17 50.15 49.97 49.29
Wavelength (A ˚ ) 0.9778 0.9330 0.9794 0.9330
Resolution limits (A ˚ ) 54–2.6 (2.74–2.6) 54–2.7 (2.85–2.7) 43–3.2 (3.37–3.2) 33–2.7 (2.85–2.7)
Completeness (%) 99.8 (99.8) 99.8 (99.8) 100.0 (100.0) 95.2 (95.2)
Anomalous completeness (%) — — 99.9 (99.9) 95.0 (73.4)
Measured reﬂections 48047 (6998) 114952 (8942) 67849 (10074) 106839 (9603)
Unique reﬂections 10006 17569 10590 16408
I/ (I) 6.1 (1.6) 7.4 (2.4) 3.9 (1.8) 7.7 (2.2)
Multiplicity 4.8 (4.9) 6.5 (3.6) 6.4 (6.7) 6.5 (5.3)
Rmerge† 9.4 (42.7) 8.7 (31.8) 16.9 (41.5) 8.0 (33.1)
Ranom‡ — — 8.3 (3.6) 4.5 (19.8)
† Rmerge = 100  
P
h½
P
i jhIðhÞi   IðhÞij=
P
i IðhÞi , where I(h)i is the ith observation of reﬂection h and hI(h)i is the mean intensity of all observations of h.‡ Ranom = 100   P
h jhIþi h I ij=
P
hðhIþiþh I iÞ, where hI
+i and hI
 i are the mean intensities of the Bijvoet pairs for observation h.
Figure 1
Orthorhombic crystals of native BipD. The largest crystal has dimensions of
approximately 20   20   300 mm.2.2. Crystallization
Initial crystallization conditions were obtained by sparse-matrix
screening (Jancarik & Kim, 1991) using the sitting-drop vapour-
diffusion technique. Drops were prepared by mixing 0.2 ml protein
solution (10 mg ml
 1,2 0m M Tris pH 6.6, 20 mM NaCl) with 0.2 ml
reservoir solution and were equilibrated against 100 ml reservoir
solution at 293 K. Initial crystals of BipD grew in two weeks in
condition No. 22 of Molecular Dimensions Stura Footprint Screen 1
(1 M trisodium citrate, 10 mM sodium borate pH 8.5). Subsequent
optimization yielded diffraction-quality crystals of BipD (Fig. 1) at
citrate concentrations in the range 1.0–1.17 M and at pH values
between 8.4 and 8.5. Crystals of SeMet-labelled BipD were grown as
described above from SeMet-labelled sample. The Pt derivative was
obtained by addition of 1 ml reservoir solution saturated with K2PtCl4
to the 0.4 ml crystallization drop; crystals were soaked for 1 d at 293 K
prior to data collection.
2.3. Data collection and processing
Crystals of native and SeMet BipD were cryoprotected in reservoir
solution containing 20% glycerol and ﬂash-cryocooled in liquid
nitrogen for data collection. The crystal of the Pt derivative of BipD
was mounted and ﬂash-cryocooled directly in the cryostream.
Diffraction data were recorded at 100 K (Table 1). Data were
indexed and integrated in MOSFLM (Leslie, 1992) and scaled with
SCALA (Evans, 1997) within the CCP4 program suite (Collaborative
Computational Project, Number 4, 1994). A ﬂuorescence scan
measured on the SeMet crystal across the Se edge yielded values of
f0 =  8.0 and f00 = 6.4 using the program CHOOCH (Evans &
Pettifer, 2001).
3. Results and discussion
Of all the BipD crystals analysed, all of which were grown under the
same conditions and all of which had a similar rod shape, only one
belonged to space group C222 (labelled Native 1), while all other
crystals examined belonged to space group P21212.
The C222 crystal contains onemolecule per asymmetric unit, with a
Matthews coefﬁcient of 2.4 A ˚ 3 Da
 1, corresponding to a solvent
content of 47% (Matthews, 1968). The P21212 crystals are likely to
contain two molecules per asymmetric unit, based on the frequency
distribution of Matthews coefﬁcients among the PDB entries at
comparable resolution (Kantardjieff & Rupp, 2003); this is conﬁrmed
by the P21212 self-rotation function peak at ! = 90, ’ = 27,   = 180 ,
which has an intensity equal to 46% of the crystallographic peaks
(Fig. 2).
The c unit-cell parameter is equal to about 49 A ˚ in both BipD
crystal forms; the estimated solvent content and unit-cell volumes are
very similar (V = 627 744 and 613 596 A ˚ 3 for C222 and P21212,
respectively), making it possible that the two lattices are equivalent.
Indeed, the cross-crystal rotation function [computed between the
C222 and P21212 forms with the program ALMN (Collaborative
Computational Project, Number 4, 1994) using data in the resolution
range 15–5 A ˚ ] has a 5  peak at ! =0 ,’ =0 ,  = 26.7  (data not
shown), suggesting that the two lattices are related by a simple
rotation around the direction of the c axis. Moreover, this cross-
crystal rotation approximately aligns the direction of the a axis of
C222 with the NCS twofold in P21212. Thus, the P21212 form is likely
to be the result of a change in symmetry that causes one of the
twofold axes in C222 to become an NCS twofold in P21212.
Anomalous difference Patterson maps for the Pt and SeMet
derivatives were calculated within autoSHARP (Vonrhein et al.,
2005) using (E
2   1) coefﬁcients and strict outlier rejection. The Pt
anomalous difference Patterson Harker sections suggest the presence
of two sites (Fig. 3), while the SeMet anomalous difference Pattersons
for the expected 2   6 = 12 Se sites are not easily interpretable (data
not shown), nor have they yielded a reliable set of Se sites, despite
attempts using the available Patterson-solving computer programs.
The current phasing strategy is therefore based on initial SIRAS
phasing with the Pt sites only, which should enable the location of the
subset of ordered Se sites in the SeMet derivative and allow MIRAS
phasing with the full BipD native data set and Pt- and SeMet-
derivative data sets.
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Figure 2
The   = 180  section of the self-rotation function calculated for the P21212 native
data set using MOLREP (Collaborative Computational Project, Number 4, 1994)
with an integration radius of 27.6 A ˚ and data in the resolution range 37–5 A ˚ .T h e
peak (marked with an X) at (!, ’) = (90, 27 ) represents 46% of the peaks for the
crystallographic twofold axes.
Figure 3
Harker section (u = 0.5) of the anomalous difference Patterson maps of the K2PtCl4
soak of BipD (space group P21212) calculated at 3.3 A ˚ resolution with data
collected at   = 0.9330 A ˚ (see Table 1) by autoSHARP. Maps are drawn with a
minimum contour level of 1.5  with 0.3  increments. The two main peaks are
labelled.Fellowship (ID-358785). Work at the IAH is supported by the
BBSRC (UK). We are grateful to Ed Lowe and Martin Noble for
collecting the diffraction data from the SeMet and K2PtCl4 deriva-
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